Rescue assays showed the inhibitive effect of OIP5-AS1 deficiency in thyroid cancer could be rescued by overexpression of CTNNB1 or addition of LiCl, which was consistent with the results in vivo. The gene discussed is CTNNB1; the disease is thyroid gland carcinoma.